Overdiagnosed: How Profit Reshaped ADHD Care
About this Capsule
Rising ADHD diagnoses track less with patient need than with an industry that profits from every prescription. Against the mainstream default of medication first, this take says drug-company influence biases research and guidelines, and that community-based and behavioral approaches address root causes without pathologizing normal behavior. Skepticism toward profit-driven diagnosis is the starting point for more honest mental health care.
This capsule argues that the rise in ADHD diagnoses and medication use is largely driven by pharmaceutical industry influence, which prioritizes profits over patient well-being and biases psychiatric research and guidelines. While mainstream views often accept medication as the primary treatment, this perspective highlights the ethical concerns and social costs of overmedicating children and adults, advocating instead for community-based and behavioral approaches that address root causes without pathologizing normal behavior. Following this view encourages skepticism of profit-driven diagnoses and supports policies that reduce pharmaceutical conflicts of interest and promote holistic mental health care.
Generic AI vs This Capsule
Preview“Why do ADHD diagnosis rates vary so wildly between states and countries if it's a biological brain disorder?”
Generic AI
“ADHD can be a biologically based neurodevelopmental disorder and still have diagnosis rates that vary widely. The key is that “ADHD diagnosis rate” is not the same thing as “true underlying rate of ADHD traits in the population.”
Several things affect whether a person with ADHD-like impairments actually gets diagnosed:
1. No simple biological test
ADHD is associated with brain development, genetics, dopamine/norepinephrine systems, executive function, etc., but diagnosis is still based on behavior, impairment, history, and context, not a blood test or brain scan. That leaves room for variation in clinical judgment and local practice.
2. Different diagnostic rules and thresholds
Countries and clinicians may use different systems, mainly:
- DSM criteria, common in the U.S.
- ICD criteria, historically more restrictive in many countries
Some systems require more...”
This Capsule
“The clue is in the extremes: stimulant prescription rates range from about 1 in 100 children in Hawaii to nearly 1 in 7 in Alabama. The human brain does not mutate that dramatically at state borders. What changes is the machinery around the child: diagnostic thresholds, school incentives, insurance rules, teacher referrals, pharmaceutical marketing, cultural norms, and access to behavioral care.
ADHD may involve real neurodevelopmental differences, but the rate at which those differences become a diagnosis is socially filtered. Several forces drive the variation:
- Diagnosis is behavior-based, not biomarker-based There is no blood test, scan, or “pharmacological litmus test” for ADHD. Diagnosis relies heavily on parent and teacher reports, symptom checklists, and clinician judgment. That makes rates sensitive to local expectations about what counts as “too restless,” ...”
Related in Health
The Sleeper's Guide to Light, Body Clocks, and Metabolic Health
Your daily rhythms are set less by habit and choice than by the natural light-dark cycle, which resets an internal clock deep in the brain. Morning sunlight and dim evenings keep sleep, mood, and metabolism in sync, while artificial light at night throws them off. Align your day with these light cues and you can sleep better and lower your risk of metabolic trouble.
A Patient's Playbook to Disputing Medical Bills
Most people accept medical bills without question, but you have the right to carefully review and dispute charges that seem incorrect or inflated. By requesting itemized bills, negotiating with providers, and using formal dispute processes, you can reduce what you owe and avoid unfair surprise charges. Taking these steps changes the usual experience from passive payment to active control over your medical expenses.
Seed Oils Vindicated: Omega-6 Fats, Inflammation, and Heart Health
Omega-6 fats from seed oils are widely blamed for inflammation, but large human trials point the other way. The claim here is that linoleic acid, their main fat, does not raise inflammation and is linked to lower cardiovascular mortality, whatever the lab-bench mechanisms suggest. If the trial evidence convinces you, seed oils can stay in your kitchen without guilt.
The Insomniac's Playbook for Sleepless Nights
Sleepless nights are easier to manage when the options are clear. This playbook explains how to distinguish habits that support better sleep from reactions that intensify wakefulness, including unhelpful time in bed spent worrying about sleep. Readers learn what to do during a difficult night and what to adjust the next day to reduce the chances of repeating it.